Agilent announced the signing of a Memorandum of Understanding (MOU) with the Sarawak Infectious Disease Centre (SIDC) in East Malaysia. The agreemen...
Ad hoc announcement pursuant to Art. 53 LR Novartis executes separation of the Sandoz business to create an independent company by way of a 100% S...
Headquartered in Beijing, China, Sino Biological is the world’s leading provider of mammalian cell-based recombinant proteins, antibodies, and relate...
Historical Perspective Traditionally, the Middle East's economy has been heavily reliant on its vast reserves of oil and natural gas. However, the region'...
“Our ongoing partnership with Bayer leverages the full suite of our Twist Biopharma Solutions offering of antibody discovery services to identify the...
Activates Standard BioTools’ strategy to unlock value in underserved portion of $100 billion industry Establishes leading platform of mu...
-Medidata, a Dassault Systèmes company and leading provider of clinical trial solutions to the life sciences industry, announced an extension ...
"Today marks an exciting milestone for Danaher. The successful spin-off of Veralto as an independent company creates exceptional opportunities for both Dan...
SPARTA technology to accelerate the development, manufacture and quality control of nanoparticles used for gene therapies, vaccines, and cancer drugs The ...
Launch of Pin-pointTM base editing reagents improves access to new-generation editing technology Access to the Pin-point system now bridges discovery, p...
Each year in Europe more than 550,000 patients are diagnosed with breast cancer, of whom 70% have estrogen receptor (ER)-positive disease¹; more tha...
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced that the European Unified Patent Court ("UPC") issued a...
“LifeSci Partners is the leading provider of healthcare advisory services, with a strong presence in the U.S., Europe and Israel. We now have a great...
“Since our founding in 2017, Herophilus’s vision has been to leverage the parallel revolutions in human complex in vitro brain models, scaled l...
© 2024 Biopharma Boardroom. All Rights Reserved.